indomethacin has been researched along with Angiogenesis, Pathologic in 39 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Excerpt | Relevance | Reference |
---|---|---|
"Indomethacin delays healing of experimental gastric ulcers." | 7.69 | Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin. ( Flogerzi, B; Halter, F; Peskar, BM; Schmassmann, A; Tarnawski, A; Varga, L, 1995) |
"Nitric oxide (NO) synthesized from L-arginine interacts with prostaglandins (PG) and sensory neuropeptides in the regulation of mucosal integrity, but the role of L-arginine, a substrate for NO-synthase, in gastroprotection and healing of chronic gastric ulcers has been little studied." | 7.69 | Role of L-arginine, a substrate for nitric oxide-synthase, in gastroprotection and ulcer healing. ( Brzozowski, T; Drozdowicz, D; Kedra, D; Konturek, SJ; Sliwowski, Z; Zaczek, M, 1997) |
" Thus, our results show that polymeric nanocapsules are able to increase the intratumoral bioavailability of indomethacin and reduce the growth of implanted gliomas." | 5.35 | Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model. ( Battastini, AM; Bernardi, A; Braganhol, E; Edelweiss, MI; Figueiró, F; Guterres, SS; Jäger, E; Pohlmann, AR, 2009) |
"Dexamethasone and indomethacin each reduced pain behavior, synovial inflammation, and synovial angiogenesis 35 days after meniscal transection." | 3.77 | Contributions of angiogenesis to inflammation, joint damage, and pain in a rat model of osteoarthritis. ( Ashraf, S; Mapp, PI; Walsh, DA, 2011) |
" Here we characterized the effects of non-selective (indomethacin) and selective (NS398, celecoxib) cyclooxygenase inhibitors on parameters of angiogenesis in human pancreatic adenocarcinoma cells." | 3.72 | Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts. ( Davis, DW; Ellis, LM; Khanbolooki, S; Lashinger, LM; McConkey, DJ; Nawrocki, S; Raut, CP; Xiong, H, 2004) |
"Indomethacin delays healing of experimental gastric ulcers." | 3.69 | Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin. ( Flogerzi, B; Halter, F; Peskar, BM; Schmassmann, A; Tarnawski, A; Varga, L, 1995) |
"Nitric oxide (NO) synthesized from L-arginine interacts with prostaglandins (PG) and sensory neuropeptides in the regulation of mucosal integrity, but the role of L-arginine, a substrate for NO-synthase, in gastroprotection and healing of chronic gastric ulcers has been little studied." | 3.69 | Role of L-arginine, a substrate for nitric oxide-synthase, in gastroprotection and ulcer healing. ( Brzozowski, T; Drozdowicz, D; Kedra, D; Konturek, SJ; Sliwowski, Z; Zaczek, M, 1997) |
"Indomethacine, protamine-sulphate and hydrocortisone were found to decrease the activity of metastatic processes of Lewis carcinoma after the removal of the primary tumour." | 3.67 | [Effect of actions inhibiting neovascularization of the metastasis of Lewis lung carcinoma]. ( Balitskiĭ, KP; Lisniak, IA; Sopotsinskaia, EB, 1985) |
"Low doses of indomethacin were applied topically to rabbit eyes in an experimental model of immunologically provoked inflammatory keratitis." | 3.66 | Inhibitors of prostaglandin synthesis and the cornea. ( Barthen, ER; Oosterhuis, JA; van Delft, JL; van Haeringen, NJ, 1983) |
"The growth rate (studied by mean tumor dry weight) and vascularization (studied by microangiography) of two transplantable rat tumors, a 20-methylcholanthrene-induced fibrosarcoma and a hepatoma, were significantly reduced by three prostaglandin synthesis inhibitors, indomethacin, diclofenac-sodium and aspirin, irrespective of whether the drugs were administered early or late during tumor growth." | 3.66 | Effects of prostaglandin synthesis inhibitors on tumor growth and vascularization. Experimental studies in the rat. ( Peterson, HI, 1983) |
"Compared with controls (R1, and anticancer drug SN-38), TA displayed prolonged tumor retention and enhanced therapeutic efficacy in xenograft mouse models at a reduced dosage." | 1.48 | COX-2 Inhibition mediated anti-angiogenic activatable prodrug potentiates cancer therapy in preclinical models. ( Han, J; Kim, HS; Kim, JS; Ren, WX; Sharma, A, 2018) |
" Thus, our results show that polymeric nanocapsules are able to increase the intratumoral bioavailability of indomethacin and reduce the growth of implanted gliomas." | 1.35 | Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model. ( Battastini, AM; Bernardi, A; Braganhol, E; Edelweiss, MI; Figueiró, F; Guterres, SS; Jäger, E; Pohlmann, AR, 2009) |
"Indomethacin can inhibit the growth of transplanted human colorectal HCT116 tumor in association with a significant reduction in angiogenesis, which may be achieved through inhibition of VEGF." | 1.32 | Experimental study of the inhibitory effect of indomethacin on the growth and angiogenesis of human colon cancer xenografts. ( Wang, HM; Zhang, GY, 2004) |
"The histamine-induced increase in the content of VEGF protein in the conditioned medium was inhibited by the cyclic AMP antagonist Rp-cAMP (IC(50) 6." | 1.31 | Enhancement by histamine of vascular endothelial growth factor production in granulation tissue via H(2) receptors. ( Ghosh, AK; Hirasawa, N; Ohuchi, K, 2001) |
"However, NSAIDs produce gastroduodenal ulcers in about 25% of users (often with bleeding and/or perforations) and delay ulcer healing, presumably by blocking prostaglandin synthesis from cyclooxygenase (COX)-1 and COX-2 (ref." | 1.30 | Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. ( Itani, RM; Jones, MK; Levin, E; Peskar, BM; Sarfeh, IJ; Tarnawski, AS; Wang, H, 1999) |
"In indomethacin-treated rabbits, however, ceruloplasmin at the same high doses failed to induce angiogenesis." | 1.26 | Role of prostaglandin E1 and copper in angiogenesis. ( Gullino, PM; Jones, J; Ziche, M, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (35.90) | 18.7374 |
1990's | 8 (20.51) | 18.2507 |
2000's | 13 (33.33) | 29.6817 |
2010's | 4 (10.26) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wu, L | 1 |
Wang, W | 2 |
Dai, M | 1 |
Li, H | 1 |
Chen, C | 1 |
Wang, D | 1 |
Kim, HS | 1 |
Sharma, A | 1 |
Ren, WX | 1 |
Han, J | 1 |
Kim, JS | 1 |
Bernardi, A | 1 |
Braganhol, E | 1 |
Jäger, E | 1 |
Figueiró, F | 1 |
Edelweiss, MI | 1 |
Pohlmann, AR | 1 |
Guterres, SS | 1 |
Battastini, AM | 1 |
Ashraf, S | 1 |
Mapp, PI | 1 |
Walsh, DA | 1 |
Silver, K | 1 |
Desormaux, A | 1 |
Freeman, LC | 1 |
Lillich, JD | 1 |
Bustuoabad, OD | 1 |
di Gianni, PD | 1 |
Franco, M | 1 |
Kordon, EC | 1 |
Vanzulli, SI | 1 |
Meiss, RP | 1 |
Grion, LC | 1 |
Díaz, GS | 1 |
Nosetto, SH | 1 |
Hockl, P | 1 |
Lombardi, MG | 1 |
Pasqualini, CD | 1 |
Ruggiero, RA | 1 |
Tanaka, K | 1 |
Watanabe, M | 1 |
Kuraishi, Y | 1 |
Kimura, I | 1 |
Suzuki, T | 1 |
Kiniwa, M | 1 |
Wang, HM | 1 |
Zhang, GY | 1 |
Fukada, SY | 1 |
Iyomasa, MM | 1 |
Cunha, FQ | 1 |
Corrêa, FM | 1 |
de Oliveira, AM | 1 |
Raut, CP | 1 |
Nawrocki, S | 1 |
Lashinger, LM | 1 |
Davis, DW | 1 |
Khanbolooki, S | 1 |
Xiong, H | 1 |
Ellis, LM | 1 |
McConkey, DJ | 1 |
Axelsson, H | 1 |
Lönnroth, C | 1 |
Svanberg, E | 1 |
Lundholm, K | 1 |
Singh, SK | 1 |
Bhusari, S | 1 |
Singh, R | 1 |
Saxena, A | 1 |
Mondhe, D | 1 |
Qazi, GN | 1 |
Sundbeck, A | 1 |
Karlsson, L | 1 |
Lilja, J | 1 |
Peterson, HI | 2 |
Ziche, M | 1 |
Jones, J | 1 |
Gullino, PM | 1 |
Rochels, R | 1 |
Schmitt, EJ | 1 |
Busse, WD | 1 |
Reim, M | 1 |
von Kiether, R | 1 |
Oglodek, C | 1 |
Schaffelt, F | 1 |
Thüne, G | 1 |
Harvey, PT | 1 |
Cherry, PM | 1 |
van Haeringen, NJ | 1 |
Oosterhuis, JA | 1 |
van Delft, JL | 1 |
Barthen, ER | 1 |
Frucht, J | 1 |
Zauberman, H | 1 |
Konturek, SJ | 2 |
Brzozowski, T | 2 |
Majka, I | 1 |
Pawlik, W | 1 |
Stachura, J | 1 |
Schmassmann, A | 1 |
Tarnawski, A | 1 |
Peskar, BM | 2 |
Varga, L | 1 |
Flogerzi, B | 1 |
Halter, F | 1 |
Colville-Nash, PR | 1 |
Alam, CA | 1 |
Appleton, I | 1 |
Brown, JR | 1 |
Seed, MP | 1 |
Willoughby, DA | 1 |
Fan, TP | 1 |
Hu, DE | 1 |
Guard, S | 1 |
Gresham, GA | 1 |
Watling, KJ | 1 |
Sliwowski, Z | 1 |
Drozdowicz, D | 1 |
Zaczek, M | 1 |
Kedra, D | 1 |
Jones, MK | 2 |
Wang, H | 1 |
Levin, E | 1 |
Itani, RM | 1 |
Sarfeh, IJ | 1 |
Tarnawski, AS | 2 |
Sawaoka, H | 1 |
Tsuji, S | 1 |
Tsujii, M | 1 |
Gunawan, ES | 1 |
Sasaki, Y | 1 |
Kawano, S | 1 |
Hori, M | 1 |
Gołab, J | 1 |
Kozar, K | 1 |
Kamiński, R | 1 |
Czajka, A | 1 |
Marczak, M | 1 |
Switaj, T | 1 |
Giermasz, A | 1 |
Stokłosa, T | 1 |
Lasek, W | 1 |
Zagozdzon, R | 1 |
Mucha, K | 1 |
Jakóbisiak, M | 1 |
Rozic, JG | 1 |
Chakraborty, C | 1 |
Lala, PK | 1 |
Ghosh, AK | 1 |
Hirasawa, N | 1 |
Ohuchi, K | 1 |
Szabó, IL | 1 |
Kawanaka, H | 1 |
Husain, SS | 1 |
Connolly, EM | 1 |
Harmey, JH | 1 |
O'Grady, T | 1 |
Foley, D | 1 |
Roche-Nagle, G | 1 |
Kay, E | 1 |
Bouchier-Hayes, DJ | 1 |
Spisni, E | 1 |
Manica, F | 1 |
Tomasi, V | 1 |
Sopotsinskaia, EB | 1 |
Lisniak, IA | 1 |
Balitskiĭ, KP | 1 |
Amemiya, K | 1 |
Suzuki, J | 1 |
Kimura, M | 1 |
Silverman, KJ | 1 |
Lund, DP | 1 |
Zetter, BR | 1 |
Lainey, LL | 1 |
Shahood, JA | 1 |
Freiman, DG | 1 |
Folkman, J | 1 |
Barger, AC | 1 |
Ohtsu, A | 1 |
Fujii, K | 1 |
Kurozumi, S | 1 |
Robin, JB | 1 |
Regis-Pacheco, LF | 1 |
Kash, RL | 1 |
Schanzlin, DJ | 1 |
Davel, LE | 1 |
Miguez, MM | 1 |
de Lustig, ES | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Evaluation of Topical Application of 5% Imiquimod, 0.05% Imiquimod and 0.05% Nanoencapsulated Imiquimod Gel in the Treatment of Actinic Cheilitis: a Randomized Controlled Trial[NCT04219358] | Phase 1 | 49 participants (Actual) | Interventional | 2019-03-23 | Terminated (stopped due to Study terminated because of COVID19 pandemics.) | ||
Radiosensitization With a COX-2 Inhibitor (Celecoxib), With Chemoradiation for Cancer of the Head and Neck[NCT00581971] | Phase 1/Phase 2 | 30 participants (Actual) | Interventional | 2002-09-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Evaluate the response to concurrent celecoxib, carboplatin, paclitaxel, and radiotherapy in the treatment of locally advanced SSC of the head and neck. Response is determined by local control only, local and distant metastasis, distant metastasis only, second primary, and surgical salvage. (NCT00581971)
Timeframe: 2 years from end of treatment (Radiation therapy)
Intervention | Participants (Number) | ||||
---|---|---|---|---|---|
Local Control Only | Local Control and Distant Metastasis | Distant Metastatsis Only | Secondary Primary - Site Unknown | Surgical Salvage | |
Recurrence | 6 | 2 | 1 | 2 | 3 |
Particpants experiencing Acute Toxicities > Grade 3 (NCT00581971)
Timeframe: 2 years from radiation therapy
Intervention | participants (Number) | ||
---|---|---|---|
Hematologic | Dermatitis | Mucositis/Dysphagia | |
Acute Toxicity | 12 | 7 | 16 |
39 other studies available for indomethacin and Angiogenesis, Pathologic
Article | Year |
---|---|
PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
Topics: Animals; Antineoplastic Agents; Benzoates; Bezafibrate; Cell Line, Tumor; Cell Movement; Cell Prolif | 2019 |
COX-2 Inhibition mediated anti-angiogenic activatable prodrug potentiates cancer therapy in preclinical models.
Topics: A549 Cells; Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 I | 2018 |
Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Body Weight; Cell Division; Cell | 2009 |
Contributions of angiogenesis to inflammation, joint damage, and pain in a rat model of osteoarthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Cartilage, Articular; Dexamethas | 2011 |
Expression of pleiotrophin, an important regulator of cell migration, is inhibited in intestinal epithelial cells by treatment with non-steroidal anti-inflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone and Bones; Carrier Proteins; Cell Line; Cell | 2012 |
Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Division; Estrogens; Female; | 2002 |
Peroral TAS-202 reduced vessel density in rats with adjuvant-induced arthritis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Blood Vessels; Dep | 2003 |
Experimental study of the inhibitory effect of indomethacin on the growth and angiogenesis of human colon cancer xenografts.
Topics: Animals; Colonic Neoplasms; Cyclooxygenase 2; Humans; Indomethacin; Isoenzymes; Membrane Proteins; M | 2004 |
Mechanisms of impaired vascular response to ANG II in perivascular injured carotid arteries of ovariectomized rat.
Topics: Angiotensin II; Animals; Calcium; Carotid Artery Injuries; Dose-Response Relationship, Drug; Endothe | 2004 |
Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts.
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Celecoxib; Cyclooxygena | 2004 |
Cyclooxygenase inhibition in early onset of tumor growth and related angiogenesis evaluated in EP1 and EP3 knockout tumor-bearing mice.
Topics: Animals; Cell Line, Tumor; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Indomethac | 2005 |
Effect of acetyl 11-keto beta-boswellic acid on metastatic growth factor responsible for angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Alkylating; Collagen; Cyclooxygenase Inhibi | 2007 |
Inhibition of tumour vascularization by tranexamic acid. Experimental studies on possible mechanisms.
Topics: Angiography; Animals; Cyclohexanecarboxylic Acids; Indomethacin; Microscopy, Electron; Muscles; Neop | 1981 |
Role of prostaglandin E1 and copper in angiogenesis.
Topics: Alprostadil; Animals; Carcinoma 256, Walker; Ceruloplasmin; Copper; Cornea; Dinoprost; Dinoprostone; | 1982 |
[Experimental inhibition of corneal neovascularization following keratoplasty].
Topics: Animals; Cornea; Corneal Transplantation; Indomethacin; Neovascularization, Pathologic; Rabbits | 1982 |
[Effect of inhibitors of prostaglandin synthesis on the eye].
Topics: Animals; Burns, Chemical; Diclofenac; Eye; Eye Burns; Eye Diseases; Humans; Indomethacin; Inflammati | 1983 |
Indomethacin v. dexamethasone in the suppression of corneal neovascularization.
Topics: Animals; Cornea; Corneal Diseases; Dexamethasone; Indomethacin; Neovascularization, Pathologic; Rabb | 1983 |
Inhibitors of prostaglandin synthesis and the cornea.
Topics: Animals; Cornea; Indomethacin; Keratitis; Neovascularization, Pathologic; Prostaglandin Antagonists; | 1983 |
Effects of prostaglandin synthesis inhibitors on tumor growth and vascularization. Experimental studies in the rat.
Topics: Animals; Aspirin; Diclofenac; Fibrosarcoma; Indomethacin; Liver Neoplasms, Experimental; Neoplasm Tr | 1983 |
Topical indomethacin effect on neovascularisation of the cornea and on prostaglandin E2 levels.
Topics: Administration, Topical; Animals; Cornea; Dinoprostone; Indomethacin; Keratitis; Neovascularization, | 1984 |
Omentum and basic fibroblast growth factor in healing of chronic gastric ulcerations in rats.
Topics: Animals; Blood Flow Velocity; Chronic Disease; Dinoprostone; Eflornithine; Fibroblast Growth Factor | 1994 |
Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin.
Topics: Animals; Bromodeoxyuridine; Drug Combinations; Female; Fibroblast Growth Factor 2; Gastric Acid; Gas | 1995 |
The pharmacological modulation of angiogenesis in chronic granulomatous inflammation.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cortisone; Dexamethasone | 1995 |
Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Histamine; Histamine H1 Antagonists; Histamine H2 Antagonists | 1993 |
Role of L-arginine, a substrate for nitric oxide-synthase, in gastroprotection and ulcer healing.
Topics: Animals; Arginine; Capsaicin; Citrulline; Dose-Response Relationship, Drug; Endothelium; Gastric Aci | 1997 |
Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase | 1999 |
Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
Topics: Animals; Apoptosis; Cell Division; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; | 1999 |
Interleukin 12 and indomethacin exert a synergistic, angiogenesis-dependent antitumor activity in mice.
Topics: Animals; Antineoplastic Agents; Cyclooxygenase Inhibitors; Drug Synergism; Drug Therapy, Combination | 2000 |
Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis.
Topics: Animals; Cell Division; Cell Movement; Cell Survival; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxyge | 2001 |
Enhancement by histamine of vascular endothelial growth factor production in granulation tissue via H(2) receptors.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cells, Cultured; Cimetidine; Cyclic A | 2001 |
von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Hypoxia; Cell Line; Endothelial Growth Factor | 2002 |
Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Apoptosis; Cyclooxygenase 1; Cyclooxygenase 2; Cyc | 2002 |
Involvement of prostanoids in the regulation of angiogenesis by polypeptide growth factors.
Topics: Allantois; Alprostadil; Animals; Chick Embryo; Chorion; Enzyme Induction; Fibroblast Growth Factors; | 1992 |
[Effect of actions inhibiting neovascularization of the metastasis of Lewis lung carcinoma].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Drug Evaluation, Preclinical; Hy | 1985 |
[Mechanism of action of pronase on chronic proliferative inflammation including granuloma angiogenesis in mice].
Topics: Animals; Collagen; Diabetes Mellitus, Experimental; Granuloma; Hydrocortisone; Hydroxyproline; Indom | 1986 |
Angiogenic activity of adipose tissue.
Topics: Adipose Tissue; Animals; Cornea; Coronary Disease; Indomethacin; Neovascularization, Pathologic; Pro | 1988 |
Induction of angiogenic response by chemically stable prostacyclin analogs.
Topics: Allantois; Animals; Biological Assay; Chick Embryo; Chorion; Dexamethasone; Epoprostenol; Indomethac | 1988 |
The histopathology of corneal neovascularization. Inhibitor effects.
Topics: Animals; Chemotaxis, Leukocyte; Cornea; Corneal Injuries; Disease Models, Animal; Electrocoagulation | 1985 |
Evidence that indomethacin inhibits lymphocyte-induced angiogenesis.
Topics: Angiogenesis Inducing Agents; Animals; Female; Indomethacin; Lymphocytes; Mammary Neoplasms, Experim | 1985 |